These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 24162715)
1. Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. Scaramuzza A; Cherubini V; Tumini S; Bonfanti R; Buono P; Cardella F; d'Annunzio G; Frongia AP; Lombardo F; Monciotti AC; Rabbone I; Schiaffini R; Toni S; Zucchini S; Frontino G; Iafusco D; Acta Diabetol; 2014 Apr; 51(2):173-84. PubMed ID: 24162715 [TBL] [Abstract][Full Text] [Related]
2. Continuous glucose monitoring and intensive treatment of type 1 diabetes. ; Tamborlane WV; Beck RW; Bode BW; Buckingham B; Chase HP; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Hirsch IB; Huang ES; Kollman C; Kowalski AJ; Laffel L; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer S; Wilson DM; Wolpert H; Wysocki T; Xing D N Engl J Med; 2008 Oct; 359(14):1464-76. PubMed ID: 18779236 [TBL] [Abstract][Full Text] [Related]
3. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes. Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500 [TBL] [Abstract][Full Text] [Related]
4. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration. Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887 [TBL] [Abstract][Full Text] [Related]
5. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ; JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683 [TBL] [Abstract][Full Text] [Related]
6. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. DiMeglio LA; Acerini CL; Codner E; Craig ME; Hofer SE; Pillay K; Maahs DM Pediatr Diabetes; 2018 Oct; 19 Suppl 27():105-114. PubMed ID: 30058221 [No Abstract] [Full Text] [Related]
7. Use of ambulatory glucose monitoring and analysis of ambulatory glucose profile in clinical practice for diabetes management; a position statement of the Arab Society of Paediatric Endocrinology and diabetes. Deeb A; Muammar T; Alsaffar H; Sedaghat S; Al Hassani N; Odeh R; Alkhayyat H; Al Sinani A; Attia N; Adhami S; Elbarbary N Diabetes Res Clin Pract; 2021 Mar; 173():108671. PubMed ID: 33493578 [TBL] [Abstract][Full Text] [Related]
8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS. Grunberger G; Handelsman Y; Bloomgarden ZT; Fonseca VA; Garber AJ; Haas RA; Roberts VL; Umpierrez GE Endocr Pract; 2018 Mar; 24(3):302-308. PubMed ID: 29547046 [TBL] [Abstract][Full Text] [Related]
9. Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM. Kesavadev J; Sadikot S; Wangnoo S; Kannampilly J; Saboo B; Aravind SR; Kalra S; Makkar BM; Maji D; Saikia M; Anjana RM; Rajput R; Singh SK; Shah S; Dhruv U; Vishwanathan V Diabetes Metab Syndr; 2014; 8(3):187-95. PubMed ID: 25200925 [TBL] [Abstract][Full Text] [Related]
10. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study. Petersson J; Åkesson K; Sundberg F; Särnblad S Pediatr Diabetes; 2019 May; 20(3):339-344. PubMed ID: 30652407 [TBL] [Abstract][Full Text] [Related]
11. Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial. Laffel LM; Hsu WC; McGill JB; Meneghini L; Volkening LK Diabetes Technol Ther; 2007 Jun; 9(3):254-64. PubMed ID: 17561796 [TBL] [Abstract][Full Text] [Related]
12. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Kaufman FR; Gibson LC; Halvorson M; Carpenter S; Fisher LK; Pitukcheewanont P Diabetes Care; 2001 Dec; 24(12):2030-4. PubMed ID: 11723078 [TBL] [Abstract][Full Text] [Related]
14. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus. Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618 [TBL] [Abstract][Full Text] [Related]
15. The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method. Bruttomesso D; Laviola L; Avogaro A; Bonora E; Del Prato S; Frontoni S; Orsi E; Rabbone I; Sesti G; Purrello F; Nutr Metab Cardiovasc Dis; 2019 May; 29(5):421-431. PubMed ID: 30952574 [TBL] [Abstract][Full Text] [Related]
17. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827 [TBL] [Abstract][Full Text] [Related]
18. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Boland E; Monsod T; Delucia M; Brandt CA; Fernando S; Tamborlane WV Diabetes Care; 2001 Nov; 24(11):1858-62. PubMed ID: 11679447 [TBL] [Abstract][Full Text] [Related]
19. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C; Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193 [TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy. Heptulla RA; Allen HF; Gross TM; Reiter EO Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]